🔎 Trials Near Me

Akèy › Kansè (tout kalite) › New Jersey › Clifton

Etid klinik pou Kansè (tout kalite) nan Clifton, NJ

15 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Clifton (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of ASP3082 in Adults With Advanced Solid Tumors

Ap rekriteFaz 1
  • Hackensack University Medical Center, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT05382559

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • Hackensack University Medical Center - John Theurer Cancer C - Lymphoma Division, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07192471

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

Ap rekriteFaz 2
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0021), Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06979596

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Ap rekriteFaz 2/3
  • Hackensack University Medical Center, Hackensack · 7 mi lwen
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT03435796

A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

Ap rekriteFaz 1
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0105), Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07030712

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

Ap rekriteFaz 1/2
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 1009), Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06818643

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Ap rekriteFaz 1
  • John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07075185

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Hackensack University Medical Center, Hackensack · 7 mi lwen
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Ap rekriteFaz 1
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT06764771

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • John Theurer Cancer Center, Hackensack · 7 mi lwen
Laj 12 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT05533697

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Ap rekriteFaz 2
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07216443

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Ap rekriteFaz 1
  • Context Investigational Site, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT06756035

Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors

Ap rekriteFaz 1/2
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 29, 2026 · NCT04145622

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Ap rekriteFaz 1
  • Hackensack University Medical Center, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT07094204

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Ap rekriteFaz 2
  • Regional Cancer Care Associates /ID# 244620, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 9, 2026 · NCT04895436

Etid Kansè (tout kalite) nan lòt vil

Lòt etid nan Clifton

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.